Pioneering Advancements to Push Boundaries in Patient Care

10:00 am - Friday 29th January 2027

  • Explore the technologies emerging after the first wave of RNAi success
  • Assess opportunities to further improve potency and durability
  • Extend the commercial and clinical impact of tissue selective RNAi therapeutics

Speakers:

Chief Technology Officer
SanegeneBio